AnaCardio

Stockholm, Sweden · Founded 2017 · Privately Held (backing)

Developer of therapeutic drugs designed to improve clinical outcomes in cardiac failure. AnaCardio is based in Stockholm, Sweden and was founded in 2017. It was valued at $293 million at its Series B in Sep 2026, the last priced event on record. It has raised $44.2 million across 1 recorded round; the latest was a Series B in Sep 2026.

PMV mark · valuation
$292.9M
Oct 2026
Priced at
its Series B
Sep 2026
Total raised
$44.2M
Last round
Series B
Sep 2026
What is AnaCardio worth?
$292.9MPrivateMarketView mark · Oct 2026

Valued at $292.9M at its Series B, Sep 2026. Nothing has traded since.

Free account
More of AnaCardio with a free account
  • ·The post-money valuation on its round
  • ·The complete investor list: 13 names
  • ·Watch AnaCardio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

1 priced round · 14 daily marks since · Sep 2026 – Oct 2026
▮▮
Series Brounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

AnaCardio funding history

1 rounds
DateRoundRaisedPost-money
Sep 2026Series B—▮
Unlock post-money valuations

Membership and data by Private Market View

AnaCardio valuation

AnaCardio was valued at $293 million at its Series B in Sep 2026. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

Recent activity

In the last 90 days, AnaCardio's record added 1 funding round.

How much has AnaCardio raised?

AnaCardio has raised $44.2 million in total; 1 of its rounds is on record. The most recent was a Series B in Sep 2026. 1 of the rounds disclosed a post-money valuation.

How AnaCardio's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For AnaCardio, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about AnaCardio

What is AnaCardio worth?
AnaCardio is valued at $292.9M as of Oct 2026. Valued at $292.9M at its Series B, Sep 2026. Nothing has traded since.
How much has AnaCardio raised?
AnaCardio has raised $44.2M in total funding across 1 recorded rounds.
When did AnaCardio last raise?
AnaCardio last raised in Sep 2026 (Series B).